PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Human Technologies, Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Human Technologies, Inc. owes ¥0.23 for every ¥1 it owns. Net profit rose 55% in the year to Mar 2026, and grew 62% a year on average over 3 years.

Compared with Technology companies in Japan · latest annual results Mar 2026.

P/E ratio

16.3

Investors pay ¥16.3 for every ¥1 of Human Technologies, Inc.'s yearly profit, lower than 54% of Technology companies in Japan.

P/B ratio

3.14

The share price is 3.14 times Human Technologies, Inc.'s book value per share, higher than 71% of Technology companies in Japan.

Market cap

¥16.5 B

The total market value of all of Human Technologies, Inc.'s shares at today's price (share price × number of shares), larger than 53% of Technology companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥5.3 B

What Human Technologies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥547.39

Net worth divided by the number of shares. The share price of ¥1,719 is 3.1 times this, which is the P/B above.

Return on equity (ROE)

20.8%

Human Technologies, Inc. earned 20.8% on its shareholders' money over the last year, higher than 83% of Technology companies in Japan.

Owes vs Owns

0.23×

Human Technologies, Inc. owes ¥0.23 for every ¥1 it owns (low), lower than 79% of Technology companies in Japan.

Dividend yield

2.02%

Human Technologies, Inc. pays 2.02% of its share price as dividends a year, lower than 63% of dividend-paying Technology companies in Japan.

Revenue growth

+24%

Revenue rose 24% in the year to Mar 2026, and grew 21% a year on average over 3 years.

Profit growth

+55%

Net profit rose 55% in the year to Mar 2026, and grew 62% a year on average over 3 years.

Profit margin

13.6%

Human Technologies, Inc. keeps ¥14 of every ¥100 of revenue as net profit.

Cash quality

0.92×

Cash from Human Technologies, Inc.'s business was 0.92× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.

Questions

What is Human Technologies, Inc.'s P/E ratio?

Investors pay ¥16.3 for every ¥1 of Human Technologies, Inc.'s yearly profit, lower than 54% of Technology companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Human Technologies, Inc.: ¥16.5 B ÷ ¥5.3 B (30 Jun 2026) = 3.1.

What is Human Technologies, Inc.'s return on equity?

Human Technologies, Inc. earned 20.8% on its shareholders' money over the last year, higher than 83% of Technology companies in Japan.

How much does Human Technologies, Inc. owe compared with what it owns?

Human Technologies, Inc. owes ¥0.23 for every ¥1 it owns (low), lower than 79% of Technology companies in Japan.

Does Human Technologies, Inc. pay a dividend?

Yes. Human Technologies, Inc. pays 2.02% of its share price as dividends a year, lower than 63% of dividend-paying Technology companies in Japan.

Is Human Technologies, Inc.'s revenue growing?

Revenue rose 24% in the year to Mar 2026, and grew 21% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.